journal article·2026-02

Ultrasound responsive violacein loaded liposomes for sonodynamic therapy

Daniel Ziental, Mikolaj Czajkowski, Aleksandra Majchrzak-Celińska, Violetta Krajka-Kuźniak, Jolanta Długaszewska, Lukasz Sobotta

Dyes and Pigments· Volume 245
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Laser-Ablation Synthesis of Nanoparticles · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. Biotechnological activities and applications of bacterial pigments violacein and prodigiosin10.1186/s13036-021-00262-9 ↗
2. Multi-target drug with potential applications: violacein in the spotlight10.1007/s11274-021-03120-4 ↗
3. Violacein and its antifungal activity: comments and potentialities10.1111/lam.13760 ↗
4. Microbial synthesis of violacein pigment and its potential applications10.1080/07388551.2021.1892579 ↗
5. Bisindole compounds—synthesis and medicinal properties10.3390/antibiotics13121212 ↗
6. Chromobacterium violaceum delivers violacein, a hydrophobic antibiotic, to other microbes in membrane vesicles10.1111/1462-2920.14888 ↗
7. Evaluation of the anti-proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines10.3892/ol.2022.13252 ↗
8. The natural pigment violacein potentially suppresses the proliferation and stemness of hepatocellular carcinoma cells in vitro
9. Violacein switches off low molecular weight tyrosine phosphatase and rewires mitochondria in colorectal cancer cells10.1016/j.bioorg.2022.106000 ↗
10. Violacein negatively modulates the colorectal cancer survival and epithelial–mesenchymal transition10.1002/jcb.30295 ↗
11. Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines10.1007/s00432-023-04930-9 ↗
12. Excited state and reactive oxygen species against cancer and pathogens: a review on sonodynamic and sono‐photodynamic therapy10.1002/cmdc.202200185 ↗
13. Sonodynamic therapy: rapid progress and new opportunities for non-invasive tumor cell killing with sound10.1016/j.canlet.2022.215592 ↗
14. Cytotoxic activity of violacein in human Colon cancer cells10.1016/j.tiv.2006.06.007 ↗
15. Violacein and its β-Cyclodextrin complexes induce apoptosis and differentiation in HL60 cells10.1016/S0300-483X(02)00751-5 ↗
16. The dual synergy of photodynamic and sonodynamic therapy in the eradication of methicillin-resistant Staphylococcus aureus10.3390/app13063810 ↗
17. Porphyrazine/phthalocyanine hybrid complexes – antibacterial and anticancer photodynamic and sonodynamic activity10.1016/j.synthmet.2023.117474 ↗
18. (chezy) doxil® — the first FDA-Approved Nano-Drug: lessons learned10.1016/j.jconrel.2012.03.020 ↗
19. Microfluidic production of mRNA-Loaded lipid nanoparticles for vaccine applications10.1080/17425247.2022.2135502 ↗
20. Insight into Theranostic nanovesicles prepared by thin lipid hydration and microfluidic method10.1016/j.colsurfb.2021.111871 ↗
21. Potential applications of violacein: a microbial pigment10.1007/s00044-011-9654-9 ↗
22. Zeta potential: a case Study of cationic, anionic, and neutral liposomes10.1007/s00216-017-0527-z ↗
23. Poly(Ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity10.1016/0005-2736(94)90003-5 ↗
24. Physicochemical characterization of liposomes after ultrasound exposure – mechanisms of drug release10.1016/j.jpba.2013.01.043 ↗
25. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes10.1016/j.chemphyslip.2009.08.003 ↗
26. Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery10.1016/j.ejpb.2010.04.012 ↗
27. Violacein induces cell death by triggering mitochondrial membrane hyperpolarization in vitro10.1186/s12866-015-0452-2 ↗
28. Interaction of violacein in models for cellular membranes: regulation of the interaction by the lipid composition at the air-water interface10.1016/j.colsurfb.2017.09.027 ↗
29. A review of the combination therapy of low frequency ultrasound with antibiotics10.1155/2017/2317846 ↗
30. Hallmarks of cancer: the next generation10.1016/j.cell.2011.02.013 ↗
31. Violacein induces death of RAS-Mutated metastatic melanoma by impairing autophagy process10.1007/s13277-016-5265-x ↗
32. Targeting immunogenic cell death in cancer10.1002/1878-0261.12851 ↗
33. Multi-Target drug with potential applications: violacein in the spotlight10.1007/s11274-021-03120-4 ↗
34. Antibacterial mode of action of violacein from Chromobacterium Violaceum UTM5 against Staphylococcus Aureus and Methicillin-Resistant Staphylococcus Aureus (MRSA)10.1007/s11356-017-8855-2 ↗
35. Polymyxins: mode of action10.1007/978-3-030-16373-0_4 ↗
36. Microbial biofilm modulation by ultrasound: current concepts and controversies10.1016/j.ultsonch.2013.05.011 ↗
37. An Insight on bacterial cellular targets of photodynamic inactivation10.4155/fmc.13.211 ↗
38. Violacein antimicrobial activity on Staphylococcus Epidermidis biofilm10.1080/14786419.2019.1569654 ↗